A) The ethics of cattle farming practices. B) The use of growth hormones in beef production. C) The import of organic beef products. D) The spread of bovine spongiform encephalopathy.
A) 1989 B) 1997 C) 2003 D) 1980
A) European Federation of Animal Health B) Council of Agriculture Ministers C) World Trade Organization (WTO) D) European Parliament
A) progesterone B) testosterone C) estradiol-17β D) zeranol
A) Canada and the United States B) Ireland and Belgium C) Italy and France D) Germany and the United Kingdom
A) Health and safety concerns. B) Economic protection of European farmers. C) Environmental impact of cattle farming. D) Animal welfare standards.
A) diethylstilbestrol B) melengestrol acetate C) zeranol D) trenbolone acetate
A) Discovery of premature puberty in schoolchildren. B) Protests by organic farmers against beef imports. C) Discovery of illegal hormones in school lunches. D) Mass death of cattle due to hormonal imbalance.
A) It was rejected by a wide margin. B) It passed by a vote of 177:1. C) It resulted in an immediate total ban. D) It was vetoed by the Council of Ministers.
A) When no consensus is reached between parties. B) When consumer groups demand it. C) When the product competes with domestic industry. D) When they present valid scientific evidence.
A) European Federation of Animal Health (FEDESA) B) European Council of Agriculture Ministers C) World Trade Organization D) European Consumers' Organisation (BEUC)
A) There is no difference between the two. B) The UK-EU dispute was resolved in 1989. C) The UK-EU dispute concerns bovine spongiform encephalopathy. D) The hormone controversy involves only Canada.
A) Leather goods. B) Ground beef. C) Dairy products. D) Edible offal.
A) To ensure cattle meat is safer for consumers. B) For cost-reduction and therapeutic purposes. C) To comply with international trade laws. D) To increase the weight of beef significantly.
A) A food preservative. B) A growth promoter. C) A natural hormone. D) A teratogen.
A) 12 July 1999 B) 12 July 1998 C) 13 February 1999 D) 13 February 1998
A) Risks from failing to observe good veterinary practice B) Risks from antibiotic resistance C) Risks from direct human consumption D) Risks from environmental degradation
A) 12 July 1999 B) 12 July 1998 C) 13 February 1999 D) 13 February 1998
A) US$116.8 million B) US$116.8 billion C) US$1.168 million D) US$16.8 million
A) No B) Yes C) Only partially D) The report does not state
A) Zeranol B) Progesterone C) 17-beta estradiol D) Testosterone
A) Comparative advantage principle B) SPS equivalence principle C) Precautionary principle D) Free trade principle
A) 45,000 tonnes B) 35,000 tonnes C) 18,500 tonnes D) 10,000 tonnes
A) 95% B) 50% C) 85% D) 75%
A) DS26 B) DS320 C) DS321 D) DS48
A) DS48 B) DS321 C) DS320 D) DS26 |